GlassScriptPhysician profile
William A Hamilton
NPI 1891892477
$4,237.70
in general payments reported to CMS, 2019-2025
39 companies · $38.14 in 2025
The $38.14 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $685 · 2021: $635 · 2022: $971 · 2023: $815 · 2024: $419 · 2025: $38.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $656.04 | 2019-2024 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.51 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $365.83 | 2019-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $292.10 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $255.13 | 2019-2023 | |
| Pfizer INC. | $241.92 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $235.26 | 2019-2023 | |
| Lilly USA, LLC | $205.10 | 2019-2024 | Mounjaro, Emgality, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $168.25 | 2021-2024 | |
| Abbott Laboratories | $133.37 | 2019-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $131.09 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $116.79 | 2022 | |
| Glaxosmithkline, LLC. | $102.51 | 2020-2024 | Trelegy Ellipta, Arexvy |
| Dexcom, INC. | $102.05 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $82.64 | 2021-2024 | Gvoke Hypopen |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.